FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


7425 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product unit of use reference set Developed by Australian Digital Health Agency true Inferred relationship Some 615170453
Medicinal product unit of use reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1364130978
Medicinal product unit of use reference set Is a Simple type reference set true Inferred relationship Some

Members
rivaroxaban 15 mg tablet
rivaroxaban 2.5 mg tablet
rivaroxaban 20 mg tablet
rivastigmine 1.5 mg capsule
rivastigmine 13.3 mg/24 hours patch
rivastigmine 2 mg/mL oral liquid
rivastigmine 3 mg capsule
rivastigmine 4.5 mg capsule
rivastigmine 4.6 mg/24 hours patch
rivastigmine 6 mg capsule
rivastigmine 9.5 mg/24 hours patch
rizatriptan 10 mg orally disintegrating tablet
rizatriptan 10 mg wafer
rizatriptan 5 mg orally disintegrating tablet
rizatriptan 5 mg wafer
rocuronium bromide 100 mg/10 mL injection, vial
rocuronium bromide 25 mg/2.5 mL injection, vial
rocuronium bromide 50 mg/5 mL injection, vial
romidepsin 10 mg injection, vial
romiplostim 230 microgram injection, vial
romiplostim 250 microgram injection, vial
romiplostim 500 microgram injection, vial
romosozumab 105 mg/1.17 mL injection, pen device
romosozumab 105 mg/1.17 mL injection, syringe
ropinirole 1 mg tablet
ropinirole 2 mg tablet
ropinirole 250 microgram tablet
ropinirole 500 microgram tablet
ropivacaine hydrochloride 100 mg/10 mL injection, ampoule
ropivacaine hydrochloride 100 mg/20 mL injection, ampoule
ropivacaine hydrochloride 150 mg/20 mL injection, ampoule
ropivacaine hydrochloride 20 mg/10 mL injection, ampoule
ropivacaine hydrochloride 200 mg/100 mL injection, bag
ropivacaine hydrochloride 200 mg/20 mL injection, ampoule
ropivacaine hydrochloride 40 mg/20 mL injection, ampoule
ropivacaine hydrochloride 400 mg/200 mL injection, bag
ropivacaine hydrochloride 50 mg/10 mL injection, ampoule
ropivacaine hydrochloride 500 mg/250 mL injection, bottle
ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use)
rosiglitazone 2 mg tablet
rosiglitazone 4 mg tablet
rosiglitazone 8 mg tablet
rosuvastatin 10 mg tablet
rosuvastatin 20 mg tablet
rosuvastatin 40 mg tablet
rosuvastatin 5 mg tablet
rotavirus pentavalent live vaccine oral liquid, 2 mL tube
rotavirus live vaccine oral liquid, 1.5 mL syringe
rotavirus live vaccine oral liquid, 1.5 mL tube
rotavirus live vaccine powder for oral liquid, vial
rotigotine 2 mg/24 hours patch
rotigotine 4 mg/24 hours patch
rotigotine 6 mg/24 hours patch
rotigotine 8 mg/24 hours patch
roxithromycin 150 mg tablet
roxithromycin 300 mg tablet
roxithromycin 50 mg dispersible tablet
rubella live vaccine injection, vial
rufinamide 100 mg tablet
rufinamide 200 mg tablet
rufinamide 400 mg tablet
rurioctocog alfa pegol 1000 units injection, vial
rurioctocog alfa pegol 1500 units injection, vial
rurioctocog alfa pegol 2000 units injection, vial
rurioctocog alfa pegol 250 units injection, vial
rurioctocog alfa pegol 3000 units injection, vial
rurioctocog alfa pegol 500 units injection, vial
ruxolitinib 10 mg tablet
ruxolitinib 15 mg tablet
ruxolitinib 20 mg tablet
ruxolitinib 5 mg tablet
sacituzumab govitecan 180 mg injection, vial
sacubitril 24.3 mg + valsartan 25.7 mg tablet
sacubitril 48.6 mg + valsartan 51.4 mg tablet
sacubitril 97.2 mg + valsartan 102.8 mg tablet
safinamide 100 mg tablet
safinamide 50 mg tablet
salbutamol 100 microgram / 1 actuation inhalation, actuation (medicinal product unit of use)
salbutamol 2 mg/5 mL oral liquid
salbutamol 2.5 mg/2.5 mL inhalation solution, ampoule
salbutamol 200 microgram powder for inhalation, 1 capsule
salbutamol 200 microgram powder for inhalation, unit dose
salbutamol 4 mg tablet
salbutamol 0.5% (5 mg/mL) inhalation solution
salbutamol 5 mg/2.5 mL inhalation solution, ampoule
salbutamol 5 mg/5 mL injection, ampoule
salbutamol 500 microgram/mL injection, ampoule
salicylic acid 10% paint
salicylic acid 12.5% collodion
salicylic acid 2% + zinc oxide 24% paste
salicylic acid 20 mg / 1 g conditioner (medicinal product unit of use)
salicylic acid 2% ointment
salicylic acid 2% solution
salicylic acid 2% shampoo
salicylic acid 27% gel
salicylic acid 40% dressing, application
salicylic acid 40% medicated dressing
salicylic acid 40% stick
salicylic acid 5% cream
salicylic acid 5% ointment
salicylic acid 6% lotion

Start Previous Page 65 of 75 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start